Compare SHASUN PHARMA with Jubilant Pharmova - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs JUBILANT PHARMOVA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA JUBILANT PHARMOVA SHASUN PHARMA/
JUBILANT PHARMOVA
 
P/E (TTM) x 123.9 15.1 819.3% View Chart
P/BV x 8.5 2.8 302.1% View Chart
Dividend Yield % 0.2 0.5 44.2%  

Financials

 SHASUN PHARMA   JUBILANT PHARMOVA
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
JUBILANT PHARMOVA
Mar-19
SHASUN PHARMA/
JUBILANT PHARMOVA
5-Yr Chart
Click to enlarge
High Rs94898 10.5%   
Low Rs46618 7.4%   
Sales per share (Unadj.) Rs214.2572.0 37.4%  
Earnings per share (Unadj.) Rs5.336.2 14.7%  
Cash flow per share (Unadj.) Rs15.859.5 26.6%  
Dividends per share (Unadj.) Rs1.004.50 22.2%  
Dividend yield (eoy) %1.40.6 240.9%  
Book value per share (Unadj.) Rs53.3301.9 17.7%  
Shares outstanding (eoy) m56.62159.28 35.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.3 24.6%   
Avg P/E ratio x13.120.9 62.6%  
P/CF ratio (eoy) x4.412.7 34.7%  
Price / Book Value ratio x1.32.5 52.2%  
Dividend payout %18.712.4 150.9%   
Avg Mkt Cap Rs m3,958120,694 3.3%   
No. of employees `000NA2.4 0.0%   
Total wages/salary Rs m2,16419,260 11.2%   
Avg. sales/employee Rs ThNM38,120.6-  
Avg. wages/employee Rs ThNM8,058.4-  
Avg. net profit/employee Rs ThNM2,414.3-  
INCOME DATA
Net Sales Rs m12,12791,108 13.3%  
Other income Rs m229357 64.2%   
Total revenues Rs m12,35691,466 13.5%   
Gross profit Rs m1,00917,390 5.8%  
Depreciation Rs m5943,709 16.0%   
Interest Rs m4152,198 18.9%   
Profit before tax Rs m23011,840 1.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-2,802 0.0%   
Tax Rs m-733,268 -2.2%   
Profit after tax Rs m3025,770 5.2%  
Gross profit margin %8.319.1 43.6%  
Effective tax rate %-31.727.6 -114.7%   
Net profit margin %2.56.3 39.3%  
BALANCE SHEET DATA
Current assets Rs m6,88445,848 15.0%   
Current liabilities Rs m8,45620,897 40.5%   
Net working cap to sales %-13.027.4 -47.3%  
Current ratio x0.82.2 37.1%  
Inventory Days Days6257 108.5%  
Debtors Days Days10851 211.1%  
Net fixed assets Rs m4,97065,498 7.6%   
Share capital Rs m113159 71.1%   
"Free" reserves Rs m2,87547,930 6.0%   
Net worth Rs m3,02048,089 6.3%   
Long term debt Rs m1,81742,429 4.3%   
Total assets Rs m13,347114,685 11.6%  
Interest coverage x1.66.4 24.3%   
Debt to equity ratio x0.60.9 68.2%  
Sales to assets ratio x0.90.8 114.4%   
Return on assets %5.46.9 77.3%  
Return on equity %10.012.0 83.4%  
Return on capital %13.312.4 107.3%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Exports (fob) Rs m5,622NA-   
Imports (cif) Rs m1,728NA-   
Fx inflow Rs m5,84312,422 47.0%   
Fx outflow Rs m2,17317,227 12.6%   
Net fx Rs m3,669-4,805 -76.4%   
CASH FLOW
From Operations Rs m39811,215 3.5%  
From Investments Rs m-1,635-10,118 16.2%  
From Financial Activity Rs m1,3096,574 19.9%  
Net Cashflow Rs m717,612 0.9%  

Share Holding

Indian Promoters % 39.2 45.6 86.0%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 3.6 8.7 41.4%  
FIIs % 17.6 21.2 83.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 21.1 187.7%  
Shareholders   20,750 23,815 87.1%  
Pledged promoter(s) holding % 12.3 15.9 77.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   STRIDES PHARMA SCIENCE  AJANTA PHARMA  UNICHEM LAB  ALEMBIC PHARMA  CADILA HEALTHCARE  

Compare SHASUN PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Over 300 Points Higher, Dow Futures Up by 86 Points(12:30 pm)

Share markets in India are presently trading on a strong note. The BSE Sensex is trading up by 379 points, up 0.8% at 49,585 levels.

Related Views on News

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY20); Net Profit Up 358.8% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 358.8% YoY). Sales on the other hand came in at Rs 24 bn (up 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY20); Net Profit Down 24.0% (Quarterly Result Update)

Feb 1, 2020 | Updated on Feb 1, 2020

For the quarter ended December 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 24.0% YoY). Sales on the other hand came in at Rs 23 bn (down 2.6% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (2QFY20); Net Profit Up 18.9% (Quarterly Result Update)

Oct 31, 2019 | Updated on Oct 31, 2019

For the quarter ended September 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 18.9% YoY). Sales on the other hand came in at Rs 23 bn (down 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY20); Net Profit Down 7.7% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 7.7% YoY). Sales on the other hand came in at Rs 22 bn (up 5.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA - AUROBINDO PHARMA COMPARISON

COMPARE SHASUN PHARMA WITH

MARKET STATS